Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma of the Oral N0 Clinical and Radiological Cavity.
NCT03947892 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2020-09-22
Summary
Squamous cell carcinoma of the VADS represents the majority of cancers in ENT. Metastatic lymph node involvement is an important prognostic factor. In N0 patients clinically and scanographically, the prevalence of cervical lymph node metastasis remains important. Only the anatomopathological analysis of cervical lymph node dissection confirms the presence of a micro-metastasis. However, new criteria of interpretation in nuclear medicine seem promising in the detection of lymph node lesions not detectable in traditional imaging.
The main objective of this study is to study the positive predictive value (PPV) of CT scans in the anatomo-pathological analysis of N0 clinical and radiological or N + unilateral neck ganglia in patients with squamous cell carcinoma of the oral cavity.
Conditions
- Squamous Cell Carcinoma of the Oral
- Clinically Node-Negative and Radiology
Interventions
- DIAGNOSTIC_TEST
-
PET-CT
A PET-CT scan will be performed systematically for all patients included with the SUVmax, SUV peak, MTV of the lesion, and up to 3 suspicious ganglia during the visual analysis.
Sponsors & Collaborators
-
University Hospital, Grenoble
lead OTHER
Principal Investigators
-
Claire DUCROZ · University Hospital, Grenoble
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-21
- Primary Completion
- 2021-08-20
- Completion
- 2021-08-20
Countries
- France
Study Locations
More Related Trials
-
Prognostic Value of 18FDG PET/CT Textural Indices in HNSCC
NCT03378193 ·Status: COMPLETED
-
Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT01179360 ·Status: COMPLETED
-
18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC
NCT04196985 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer
NCT06171464 ·Status: COMPLETED
-
Performance of PET 18 F-FDG Coupled to CT With Contrast Injection Iodized in the Diagnosis of Early Recurrences of Head and Neck Carcinoma Treated With Concurrent Chemoradiation. Comparison With 18F-FDG PET Coupled With CT Not Injected With Filling CT Standard Injection
NCT02510872 ·Status: COMPLETED ·Phase: NA
-
Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy
NCT01269970 ·Status: COMPLETED
-
The EMINENCE Study - PET/MR Imaging of Head Neck Cancer
NCT04612075 ·Status: RECRUITING
-
Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma
NCT03817307 ·Status: UNKNOWN ·Phase: NA
-
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
NCT00388024 ·Status: COMPLETED
-
Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma
NCT02515084 ·Status: COMPLETED ·Phase: PHASE2
-
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
NCT00313027 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.
NCT03830242 ·Status: UNKNOWN ·Phase: NA
-
Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer
NCT04008095 ·Status: COMPLETED
-
SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification
NCT04803331 ·Status: UNKNOWN ·Phase: NA
-
PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy
NCT00809016 ·Status: COMPLETED ·Phase: NA
-
The Diagnostic Value of PET/MRI in Head and Neck Cancer
NCT04117139 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer
NCT01235052 ·Status: COMPLETED ·Phase: NA
-
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
NCT00904410 ·Status: COMPLETED ·Phase: PHASE4
-
PET MRI as a Staging Tool for Head and Neck Cancer
NCT04750434 ·Status: COMPLETED
-
Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer
NCT00199680 ·Status: UNKNOWN ·Phase: PHASE2
-
Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis
NCT05762172 ·Status: COMPLETED ·Phase: NA
-
Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival
NCT01261598 ·Status: COMPLETED ·Phase: NA
-
Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCC
NCT04514822 ·Status: UNKNOWN ·Phase: NA
-
Pseudo-Simultaneous Imaging of Tumor Hypoxia and Proliferation in HNC Patients Using PET/CT
NCT03548727 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
PET With [18F]HX4 in Head and Neck Cancer
NCT01347281 ·Status: COMPLETED ·Phase: NA